 |
 |
Hi %%First_name%%,
Clinical trials have resisted real innovation, not because we couldn’t, but because we feared failure. But pressure has built, floodgates have opened, and technology is transforming time-to-market, how we recruit and retain participants, and how we gather data. Regulators are embracing new methods. It’s time for new types of trial: democratized, patient-preferred, siteless and virtual. Are your clinical teams ready?
If you had to pause before answering that, ready on.
You’re not alone – which is why we have pulled together over 15 clinical innovation leaders to show you how to transform your trial experience for patients – in what we believe is one of the most progressive clinical trial conferences ever! Join us at the Digital Clinical Trial Conference on April 15-16th in Philadelphia and deliver on the promise of the patient-preferred trial.
Biopharma executives can apply to attend for FREE. Attend for free here.
The only clinical trials conference in 2020 that is dedicated to helping you navigate the digital transformation in clinical trials. Sign-up for free (if you work for a biopharma company) and you will:
- Learn how the leaders in clinical innovation shift seamlessly from pilot to worldwide trial
- Gain insights into how to combine RWE and clinical evidence to find unmet need and build a compelling case for regulators
- Find out how others, who have gone before you, have overcome privacy, regulatory and compliance challenges
When you attend, you’ll gain insights from clinical innovation leaders including:
- Juliette Chen, Director, Global Outcomes Research and Epidemiology, Takeda
- Jacob LaPorte, Co-founder, BIOME, Novartis
- Irfan Khan, CEO, Circuit Clinical
- Kelly McKee, Head, Patient Recruitment and Patient-Centric Innovation, Vertex
- Mary Elmer, Executive Director, Merck
- Anne Marie Inglis, Senior Director Clinical Operations, GSK
- Monique Adams, Director, Clinical Innovation, Janssen
- Kendal Whitlock, Metasite Strategic Engagement Lead, Boehringer Ingelheim
- Jamie Roberts, Director, Clinical Research Networks & Recruitment Innovation, CTSI, Duke University
- Patrick Nadolny, Global Head, Clinical Data Management and Programming, Allergan
- Carrie Northcott, Digital Medicine and Translational Imaging, Pfizer
- Matt Bryant, Executive Director, Head of Technology & Innovation Global Development and Clinical Operations at Gilead Sciences, Gilead
- Ariel Dowling, Associate Director of Digital Clinical Devices, Takeda
- Laura Kling, Digital Catalyst, Sanofi
- Ken Getz, Deputy Director and Professor, CSDD, Tufts University School of Medicine
- Nikhil Kavimandan, Program Director Innovation and Senior Fellow, Novartis
- Judy Sewards, VP, Head of Clinical Trial Experience, Pfizer
- Bari Kowal, Vice President & Head, Global Clinical Operations, Regeneron
- David Leventhal, Senior Director, Clinical Trial Experience, Pfizer
- Dalvir Gill, CEO, Transcelerate
Spaces are limited – register now to claim your free pass (for biopharma executives only).
Best Regards,
Saskia Burbach
Global Conference Director
eyeforpharma by Reuters Events |
|